Septic Arthritis Market Research Report - Forecast till 2027

Septic Arthritis Market Information: By Diagnosis (Joint Fluid Analysis, Blood Tests, Imaging), Treatment (Antibiotics, Surgery), Indication (Arthritis, Diabetes,), End User (Orthopedic Hospitals, Clinics, Diagnostic Centers) - Forecast till 2027

ID: MRFR/Pharma/3183-HCR | February 2021 | Region: Global | 110 pages

Septic Arthritis Market Speak to Analyst Request a Free Sample

Market Synopsis of Septic Arthritis Market


Septic arthritis is a disease caused by a bacterial infection or invasion in the joints leading to inflammation. Symptoms of septic arthritis include redness, heat, and pain in the joints reducing their movement. It is caused by bacteria, viruses, fungi, and parasites. Diabetes, osteoarthritis, gout, rheumatoid arthritis, joint trauma and poor immune function are major risk factors for septic arthritis.


The septic arthritis market is driven by an increasing prevalence of chronic diseases such as diabetes, rheumatoid arthritis, availability of cost effective treatment and extensive research and development activities in internal medicine. There is an increasing demand for the new drugs for the treatment of septic arthritis which further fuels the growth of the septic arthritis market.


Bacterial resistance to commonly used antibiotics such as vancomycin may restrain for the growth of the septic arthritis market. Fierce competition among key market players acts as a barrier for the new entrants in the septic arthritis market.


The septic arthritis market is expected to grow at a CAGR of 7.5% during the forecast period.


Segments                                                                                                                                            


The septic arthritis market is segmented on the basis of diagnosis, treatment, indication, and end user.


On the basis of diagnosis, septic arthritis market is segmented into joint fluid analysis, blood tests, imaging and others. Imaging is further segmented into X-ray, ultrasonography, MRI, and CT scan.


On the basis of treatment, the septic arthritis market is segmented into antibiotics, aspiration of the joint, surgery, and others. Surgery is further segmented into arthrotomy and arthroscopy.


On the basis of indication, the septic arthritis market is segmented into arthritis, hip or knee prosthesis, poor immune function, joint surgery, and others.


On the basis of end user, the septic arthritis market is segmented into orthopedic hospitals, clinics, pharmaceutical companies, and others.


FIGURE 1: Global Septic Arthritis Market by Region, 2016 (%) Septic Arthritis Market


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Research Methodology Global Septic Arthritis Market


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation

Regional Analysis of theSeptic Arthritis Market                       


America is the largest market for septic arthritis owing to the rising prevalence of septic arthritis in the U.S., According to the Center for Disease Control and Prevention, an estimated 78 million (26%) U.S. adults aged 18 years or older are projected to have doctor-diagnosed arthritis by 2040. Furthermore, arthritis prevalence was the highest among people 65 years and older, women, and obese population.


Europe is the second largest septic arthritis market owing to the rising prevalence of rheumatoid arthritis in European countries and availability of funds for research and development activities.


The market in Asia Pacific is expected to grow at the fastest pace and is driven by the increasing geriatric population, rising prevalence of chronic disease such as diabetes, and obesity, and changing lifestyles of the people. Diabetes is one of the major problems further creating opportunities for the septic arthritis market growth.


The Middle East & Africa also show a steady rise in the market owing to increasing prevalence of diabetes and other chronic diseases.


Key Players in the Septic Arthritis Market        


Some of the key players in the septic arthritis market are Lupin Pharmaceuticals, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Swtizerland), AbbVie Inc. (U.S.), Amgen Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Johnson & Johnson Inc. (U.S.), and Pfizer (U.S.).


Intended Audience



  • Arthritis Drug Manufacturers

  • Arthritis Drug Suppliers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


 



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   7.5% (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Diagnosis, Treatment, Indication, and End user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Lupin Pharmaceuticals, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Swtizerland), AbbVie Inc. (U.S.), Amgen Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Johnson & Johnson Inc. (U.S.), and Pfizer (U.S.)
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Increasing prevalence of chronic diseases
  • Availability of cost effective treatment
  • Extensive research and development activities in internal medicine
  • Increasing demand for the new drugs for the treatment of septic arthritis


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The septic arthritis market CAGR would be 7.5% during the forecast period.

    The septic arthritis market report has joint fluid analysis, blood tests, imaging, and others as a part of diagnostic segmentation.

    The septic arthritis market report includes treatments like antibiotics, aspiration of the joint, surgery, and others.

    The Americas would lead the septic arthritis market.

    The APAC region would be the fastest-growing septic arthritis market.